973
Articles
44.9K
Citations
4.6
avg. Impact Factor
97
h-index

Most Cited Articles of Department of Pathology in 2013

TitleJournalYearCitations
Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cellsClinical Cancer Research2013485
Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemiaMolecular Therapy2013299
A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancerJournal of Hematology and Oncology2013230
TIM3FOXP3 regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancerOncoImmunology2013193
The cell-cycle regulator CDK4: an emerging therapeutic target in melanomaClinical Cancer Research2013182
Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attackBlood2013153
Synthetic lethality between CCNE1 amplification and loss of BRCA1Proceedings of the National Academy of Sciences of the United States of America2013142
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomasJournal of Pathology2013139
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridizationModern Pathology2013119
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistryAmerican Journal of Surgical Pathology2013109
Blockade of PD-1 immunosuppression boosts CAR T-cell therapyOncoImmunology201386
RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovaryJournal of Pathology201381
Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templatesClinical Chemistry201381
Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancerClinical Cancer Research201379
Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primaryJournal of Pathology201373
Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutationsClinical Cancer Research201367
Laminin-511: a multi-functional adhesion protein regulating cell migration, tumor invasion and metastasisCell Adhesion and Migration201355
Hypoxia-driven immunosuppression contributes to the pre-metastatic nicheOncoImmunology201351
High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohortPLoS ONE201344
Unravelling the molecular complexity of GPCR-mediated EGFR transactivation using functional genomics approachesFEBS Journal201343
Functional analysis of genes in regions commonly amplified in high-grade serous and endometrioid ovarian cancerClinical Cancer Research201341
HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stromaBreast Cancer Research201340
Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cellsImmunology and Cell Biology201339
Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumoursScientific Reports201338
Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part IV - postanalytic considerationsCytometry Part B - Clinical Cytometry201337